Regulation of TCR signaling by a novel enzyme activity.
Regulation of TCR signaling by a novel enzyme activity.
批准号:
7297150
负责人:
NICHOLAS A CARPINO
金额:
$19.38万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-09-20 至 2009-08-31
关键词:
AntigensApplications GrantsAreaAutoimmune DiseasesAutoimmunityBiochemicalBiochemistryCCL4 geneCellsCuesDataDefectDisruptionEmployee StrikesEngineeringEnsureEnzymesEtiologyGenesGoalsHeartImmune System DiseasesImmune responseImmune systemLaboratoriesLightLinkModelingMouse StrainsMultiple SclerosisMusOutcomePathologyPeripheralPhenotypePhosphoric Monoester HydrolasesPhosphorylationPlayPredispositionProductionProliferatingPropertyProteinsProtocols documentationRangeReceptor SignalingRegulationResearchResearch Project GrantsRoleShapesSignal PathwaySignal TransductionStreamT-Cell ActivationT-Cell ReceptorT-LymphocyteTestingTranslatingUpper armZAP-70 Genecytokinedesignenzyme activitymouse modelmutantnovelpathogenpreventprogramsreceptorresearch studyresponse
中文摘要
描述(由申请人提供):T细胞自身反应性是许多自身免疫性疾病的核心,它源于允许T细胞产生有效免疫反应的特性。因此,要了解不同自身免疫性疾病的病因,就需要对控制T细胞活化的机制有全面和综合的了解。我研究的长期目标是了解T细胞反应性的生物化学。目前,我的实验室正在研究Sts-1和Sts-2两种相关蛋白如何协同作用,负向调节T细胞信号通路。Sts-1和-2在控制TCR信号通路中的作用通过缺乏Sts基因的小鼠菌株被揭示。来自st - 1/2-/-小鼠的T细胞在TCR刺激下急剧超增殖。在多发性硬化症小鼠模型中,这种高增殖表型伴随着TCR下游信号通路的激活增加、细胞因子产生水平升高以及Sts-1/2-/-小鼠对自身免疫的易感性增加。在我们持续努力表征Sts蛋白功能的过程中,我们最近发现Sts-1具有一种新的强大的酶活性。这种活性来源于蛋白质内部的一个进化上保守的区域,我们最近的数据表明它在Sts-1调节TCR信号通路的能力中起着至关重要的作用。Sts-1与其他已知的酶完全不同,使其成为一种新颖而独特的磷酸酶。此外,Sts-1催化活性与T细胞活化调控之间的联系尚不清楚。本提案中概述的实验旨在阐明这些领域。我们的具体目标是:1;确定定义和调节Sts-1催化活性的结构特征。2. 确定Sts-1磷酸酶活性在调控Zap-70信号传导中的作用。我们将使用一些最近开发的协议来实现我们的目标。本文所述的研究的完成将有助于我们建立一个Sts-1如何与Sts-2和其他细胞内信号机制合作控制T细胞反应性的模型。我们希望,对控制T细胞活化的所有机制的广泛、综合的理解将转化为预防各种自身免疫性疾病发作的治疗方法。当免疫系统内正常的调节机制失效时,自身免疫性疾病就会出现。开发预防或治愈自身免疫性疾病的疗法需要对控制免疫反应的机制有全面和综合的了解。这个项目的重点是了解一种参与T细胞活化调节的新蛋白的功能。
英文摘要
DESCRIPTION (provided by applicant): The T cell auto-reactivity that lies at the heart of many autoimmune diseases arises from the very properties that allow T cells to mount an effective immune response. Thus, to understand the etiology of different autoimmune diseases will require a thorough and integrated understanding of the mechanisms that control T cell activation. The long-term objective of my research is to understand the biochemistry of T cell reactivity. Currently, my laboratory is studying how two related proteins, Sts-1 and Sts-2, act in concert to negatively regulate T cell signaling pathways. The role of Sts-1 and -2 in controlling TCR signaling pathways was revealed by a strain of mice engineered to lack the Sts genes. T cells from Sts- 1/2-/- mice dramatically hyper-proliferate in response to TCR stimulation. This hyper-proliferative phenotype is accompanied by increased activation of signaling pathways downstream of the TCR, elevated levels of cytokine production, and increased susceptibility of Sts-1/2-/- mice to autoimmunity in a mouse model of multiple sclerosis. In our ongoing effort to characterize the functions of the Sts proteins, we recently discovered that Sts-1 has a novel and potent enzyme activity. This activity derives from an evolutionarily conserved region within the protein and our recent data indicates that it plays an essential role in the ability of Sts-1 to regulate TCR signaling pathways. Sts-1 is sufficiently dissimilar to other known enzymes to make it a novel and unique phosphatase. In addition, the connection between Sts-1 catalytic activity and regulation of T cell activation in unknown and unexplored. The experiments outlined in this proposal are designed to shed light on these areas. Our Specific Aims are: 1. To determine the structural features that define and regulate Sts-1 catalytic activity. 2. To determine the role of Sts-1 phosphatase activity in regulating Zap-70 signaling. We will use some recently developed protocols to accomplish our goals. Completion of the studies described herein will help us build a model of how Sts-1 cooperates with Sts-2 and other intracellular signaling mechanisms to control T cell reactivity. It is our hope that a broad, integrated understanding of all the mechanisms that control T cell activation will translate into therapies that prevent the onset of a variety of autoimmune diseases. Autoimmune diseases arise when normal regulatory mechanisms within the immune system fail. Developing therapies that will prevent or cure autoimmune diseases will require a thorough and integrated understanding of the mechanisms that control the immune response. This project focuses on understanding the function of a novel protein that participates in the regulation of T cell activation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Optimizing the immune response by targeting the Sts enzymes
-
批准号:10058243
-
项目类别:
-
资助金额:$60.42万
-
财政年份:2018
-
负责人:NICHOLAS A CARPINO
-
依托单位:
Optimizing the immune response by targeting the Sts enzymes
-
批准号:10305609
-
项目类别:
-
资助金额:$56.35万
-
财政年份:2018
-
负责人:NICHOLAS A CARPINO
-
依托单位:
Regulation of TCR Signaling by Sts-1 and Sts-2
-
批准号:8197150
-
项目类别:
-
资助金额:$38.41万
-
财政年份:2009
-
负责人:NICHOLAS A CARPINO
-
依托单位:
Regulation of TCR Signaling by Sts-1 and Sts-2
-
批准号:7997173
-
项目类别:
-
资助金额:$38.41万
-
财政年份:2009
-
负责人:NICHOLAS A CARPINO
-
依托单位:
Regulation of TCR Signaling by Sts-1 and Sts-2
-
批准号:8582528
-
项目类别:
-
资助金额:$38.41万
-
财政年份:2009
-
负责人:NICHOLAS A CARPINO
-
依托单位:
Regulation of TCR Signaling by Sts-1 and Sts-2
-
批准号:8384886
-
项目类别:
-
资助金额:$36.11万
-
财政年份:2009
-
负责人:NICHOLAS A CARPINO
-
依托单位:
Regulation of TCR Signaling by Sts-1 and Sts-2
-
批准号:7791969
-
项目类别:
-
资助金额:$38.66万
-
财政年份:2009
-
负责人:NICHOLAS A CARPINO
-
依托单位:
Regulation of TCR signaling by a novel enzyme activity.
-
批准号:7497542
-
项目类别:
-
资助金额:$22.81万
-
财政年份:2007
-
负责人:NICHOLAS A CARPINO
-
依托单位:
JAK2 MEDIATED SIGNAL TRANSDUCTION
-
批准号:6377520
-
项目类别:
-
资助金额:$1.64万
-
财政年份:2001
-
负责人:NICHOLAS A CARPINO
-
依托单位:
JAK2 MEDIATED SIGNAL TRANSDUCTION
-
批准号:6173911
-
项目类别:
-
资助金额:$3.75万
-
财政年份:2000
-
负责人:NICHOLAS A CARPINO
-
依托单位:
JAK2 MEDIATED SIGNAL TRANSDUCTION
-
批准号:6013193
-
项目类别:
-
资助金额:$3.17万
-
财政年份:1999
-
负责人:NICHOLAS A CARPINO
-
依托单位: